Intracardiac QRS electrogram width - An arrhythmia detection feature for implantable cardioverter defibrillators: Exercise induced variation as a base for device programming

PACE - Pacing and Clinical Electrophysiology

Volumn 21, Issue 8, 1998, Pages 1609-1617

  Klingenheben, Thomas ^a   Sticherling, Christian ^a   Skupin, Manfred ^b   Hohnloser, Stefan H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Department of Surgery   (Germany)

Author keywords

Arrhythmia detection criteria; Implantable defibrillator; Inappropriate shocks

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; ELECTROCARDIOGRAPHY; EXERCISE; FEMALE; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; QRS COMPLEX;

DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 0031857916     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1998.tb00250.x     Document Type: Article

References (22)

1. Mitrani RD, Klein LS, Rardon DP, et al. Current trends in the implantable cardioverter defibrillator. In DP Zipes, J Jalife (eds.): Cardiac electrophysiology. Philadelphia, PA, W.B. Saunders, 1995, pp. 1393-1403.
2. Weber M, Boecker D, Block M, et al. Inappropriate ICD therapies: Incidence, causes, risk factors and prevention. In E Adorno (ed.): Therapies for cardiac arrhythmias in 1996: Where are we going? Roma, Italy, Edizioni Luigi Pozzi, 1996, pp. 183-194.
3. Grimm W, Flores BF, Marchlinski FE. Electrocardiographically documented unnecessary spontaneous shocks in 241 patients with implantable cardioverter-defibrillators. PACE 1992; 15:1667-1673.
4. Chapman PD, Troup P. The automatic implantable cardioverter-defibrillator: Evaluating suspected inappropriate shocks. J Am Coll Cardiol 1986; 7:1075-1078.
5. Neuzner J, Schlepper M. New algorithms for discrimination between supraventricular and ventricular tachyarrhythmias in patients with implantable cardioverter defibrillator. Herzschr Elektrophys 1997; 8(Suppl 1):53-61.
6. Olson WH, Bardy GH, Mehra R, et al. Onset and stability for ventricular tachyarrhythmia detection in an implantable cardioverter-defibrillator. In Computers in Cardiology, New York, IEEE Press, 1987, pp.167-170.
7. Higgins SL, Lee RS, Kramer RL. Stability: An ICD detection criterion for discriminating atrial fibrillation from ventricular tachycardia. J Cardiovasc Electrophysiol 1995; 6:1081-1088.
8. Neuzner J, Pitschner HF, Schlepper M. Programmable VT detection enhancements in implantable cardioverter defibrillator therapy. PACE 1995; 18:539-547.
9. Barold HS, Newby KH, Tomassoni G, et al. Prospective evaluation of new and old criteria to discriminate between supraventricular and ventricular tachycardia in the Medtronic 7218C implantable defibrillator. (abstract) Circulation 1996; 94(Suppl):3320.
10. Brachmann J, Swerdlow CD, Mitchell BL, et al. for the Worldwide 7218 ICD investigators. Worldwide experience with the electrogram width feature for improved detection in an implantable pacer-cardioverter-defibrillator. (abstract) J Am Coll Cardiol 1997; 28(Suppl):115A.
11. Brachmann J, Seidl K, Hauer B, et al. Intracardiac electrogram width measurement for improved tachycardia discrimination: Initial results of a new implantable cardioverter-defibrillator. (abstract) J Am Coll Cardiol 1996; 27(Suppl):96A.
12. Zipes DP. Autonomic modulation of cardiac arrhythmias. In DP Zipes, J Jalife (eds.): Cardiac Electrophysiology. Philadelphia, PA, W.B. Saunders, 1995, pp. 441-453.
13. Patterson E, Szabo B, Scherlag BJ, et al. Arryhthmogenic effects of antiarrhythmic drugs. In DP Zipes, J Jalife (eds.): Cardiac Electrophysiology. Philadelphia, PA, W.B. Saunders, 1995, pp. 496-511.
14. Lehmann MH, Saksena S. NASPE Policy Statement: Implantable cardioverter defibrillators in cardiovascular practice: Report of the policy conference of the North American Society of Pacing and Electrophysiology. PACE 1991; 14:969-979.
15. Dreifuc LS, Fisch C, Griffin JC, et al. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. J Am Coll Cardiol 1991; 18: 1-13.
16. Schmitt C, Montero M, Melichercik J. Significance of supraventricular tachyarrhythmias in patients with implantable pacing cardioverter defibrillators. PACE 1994; 17:295-302.
17. Pinski SL, Fahy GJ. The proarrhythmic potential of implantable cardioverter-defibillators. Circulation 1995; 92:1651-1664.
18. Cohen TJ, Chien WW, Lurie KG, et al. Implantable cardioverter defibrillator proarrhythmia: Case report and review of the literature. PACE 1991; 14:1326-1329.
19. Schaumann A, von zur Mühlen F, Gonska BD, et al. Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy. AmJ Cardiol 1996; 78(Suppl 5A):42-50.
20. Chiang CM, Jenkins JM, DiCarlo LA. The value of rate regularity and multiplicity measures to detect ventricular tachycardia in the presence of atrial fibrillation or flutter. PACE 1994; 17:1503-1508.
21. LeCarpentier GL, Baga JJ, Yang H, et al. Differentiation of sinus tachycardia from ventricular tachycardia with 1:1 ventriculoatrial conduction in dual chamber implantable cardioverter defibrillators: Feasibility of a criterion based on the atrioventricular interval. PACE 1994; 17:1818-1831.
22. Throne RD, Jenkins JM, DiCarlo LA. A comparison of four new time-domain techniques for discriminating monomorphic ventricular tachycardia from sinus rhythm using ventricular waveform morphology. IEEE Trans Biomed Eng 1991; 38: 561-570.